Do‐Youn Oh
Impact in
- Oncology top 0.05%
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 437
- Pancreatic and Hepatic Oncology Research 129
- Colorectal Cancer Treatments and Studies 102
- HER2/EGFR in Cancer Research 71
- Cancer Immunotherapy and Biomarkers 53
-
- Gastrointestinal Tumor Research and Treatment 50
- Co-authors
- Yung‐Jue BangSeock‐Ah ImSae‐Won HanTae‐You KimLuca GianniMark D. PegramSunil VermaDavid Miles
- Journals
- Journal of Clinical Oncology (166 papers)Annals of Oncology (44 papers)Cancer Research and Treatment (35 papers)BMC Cancer (19 papers)Cancer Research (17 papers)
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
Do‐Youn Oh
552 papers receiving 20.5k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Oncology 14.9k
- Cancer Research 4.2k
- Pulmonary and Respiratory Medicine 6.6k
- Surgery 5.4k
- Pathology and Forensic Medicine 2.1k
Countries citing papers authored by Do‐Youn Oh
This map shows the geographic impact of Do‐Youn Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Do‐Youn Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Do‐Youn Oh more than expected).
Fields of papers citing papers by Do‐Youn Oh
This network shows the impact of papers produced by Do‐Youn Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Do‐Youn Oh. The network helps show where Do‐Youn Oh may publish in the future.
Co-authors
The 25 scholars most cited alongside Do‐Youn Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 8 | |
| 11 | 2023 | 3 | |
| 12 | 2021 | 24 | |
| 13 | 2021 | 10 | |
| 14 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer Hit paper breakdown → | 2019 | 1468 |
| 15 | 2019 | 34 | |
| 16 | 2017 | 105 | |
| 17 | 2016 | 9 | |
| 18 | 2015 | 52 | |
| 19 | 2013 | 109 | |
| 20 | 2011 | 58 |
About Do‐Youn Oh
Do‐Youn Oh is a scholar working on Oncology, Gastroenterology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 573 papers that have together received 20.9k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (152 papers), Pancreatic and Hepatic Oncology Research (129 papers), Gastric Cancer Management and Outcomes (116 papers), Colorectal Cancer Treatments and Studies (102 papers), HER2/EGFR in Cancer Research (71 papers), Cancer Immunotherapy and Biomarkers (53 papers), Gastrointestinal Tumor Research and Treatment (50 papers) and Lung Cancer Treatments and Mutations (50 papers). The work is most often cited by research in Oncology (14.9k citations), Cancer Research (4.2k citations), Pulmonary and Respiratory Medicine (6.6k citations), Surgery (5.4k citations) and Pathology and Forensic Medicine (2.1k citations). Do‐Youn Oh has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Yung‐Jue Bang, Seock‐Ah Im, Sae‐Won Han, Tae‐You Kim, Luca Gianni, Mark D. Pegram, Sunil Verma, David Miles, Ellie Guardino and Steven R. Olsen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research and Treatment, BMC Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.